Tag: anemia

American Regent’s HEART-FID trial for INJECTAFER fails to meet primary endpoint

businessnewstoday- August 27, 2023

American Regent, Inc., a subsidiary of Daiichi Sankyo Group, has announced disappointing results from its phase 3 HEART-FID trial of INJECTAFER (ferric carboxymaltose injection) for ... Read More

Effective home remedies for Anemia: boosting iron levels naturally

businessnewstoday- May 28, 2023

Anemia occurs when the blood lacks an adequate amount of hemoglobin, the compound responsible for carrying oxygen throughout the body. Causes, Symptoms, and Types of ... Read More

Novo Nordisk acquires SCD drug developer Forma Therapeutics

businessnewstoday- October 16, 2022

Novo Nordisk acquisition of Forma Therapeutics : Danish pharma company Novo Nordisk has closed the previously announced $1.1 billion acquisition of Forma Therapeutics, a clinical-stage ... Read More

Zydus Lifesciences launches Revlimid generic – Lenalidomide Capsules in US

pallavi123- September 20, 2022

Indian pharma company Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited has launched Lenalidomide Capsules, a generic of Revlimid, in the US market. The ... Read More

Agios Pharmaceuticals gets PYRUKYND FDA approval for hemolytic anemia

pallavi123- February 20, 2022

Agios Pharmaceuticals has secured approval for PYRUKYND (mitapivat) from the US Food and Drug Administration (FDA) for the treatment of hemolytic anemia in adult patients ... Read More

Astellas, FibroGen get extended Roxadustat approval in Japan for anemia of CKD

pharmanewsdaily- November 28, 2020

Roxadustat approval - Astellas Pharma and FibroGen have secured approval for EVRENZO (roxadustat) in Japan for the treatment of anemia associated with chronic kidney disease ... Read More

EC approves Reblozyl for transfusion-dependent anemia in adults

pharmanewsdaily- June 28, 2020

Bristol Myers Squibb and Acceleron Pharma have secured approval from the European Commission (EC) for their jointly developed erythroid maturation agent Reblozyl (luspatercept) for the ... Read More

Celgene, Acceleron bag Reblozyl FDA approval for anemia in beta thalassemia

pharmanewsdaily- November 9, 2019

Reblozyl FDA approval : Celgene and Acceleron Pharma have bagged approval from the US Food and Drug Administration (FDA) for Reblozyl (luspatercept-aamt) for the treatment ... Read More